WST

West Pharmaceutical Services
D

WST

Arincen83/100B
413.00
USD
1.73
(0.42%)
Market Open
Last updated: · Delayed 15 min
Fair value379.45Plus+9%222Price 413.00531
Q4 FY2026 · Earnings report
EPS estimate 2.27Revenue estimate 825.22M
OverviewFinancialsForecastEarningsDividendsCompany

West Pharmaceutical Services revenue 1985–2026

West Pharmaceutical Services's revenue in Q3 FY2026, the three months to 30 September 2026, was 874.50M USD, up 8.7% on the same quarter a year before. West Pharmaceutical Services's revenue over the last twelve months was 3.40B USD, up 12.6% on the twelve months before. In fiscal year 2025 it was 3.07B USD, up 6.3% on the year before.

Last updated 9 Nov 2026 · Next report 11 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 20263.40B+12.58%1.28B638.90M
FY202531 Dec 20253.07B+6.26%1.10B493.70M
FY202431 Dec 20242.89B-1.98%1.00B492.70M
FY202331 Dec 20232.95B+2.27%1.13B593.40M
FY202231 Dec 20222.89B+1.94%1.14B585.90M
FY202131 Dec 20212.83B+31.86%1.17B661.80M
FY202031 Dec 20202.15B+16.44%767.90M346.20M
FY201931 Dec 20191.84B+7.31%608.80M241.70M
FY201831 Dec 20181.72B+7.36%546.30M206.90M
FY201731 Dec 20171.60B+6.04%514.80M150.70M
FY201631 Dec 20161.51B+7.95%501.00M143.60M
FY201531 Dec 20151.40B-1.67%454.10M95.60M
FY201431 Dec 20141.42B+3.91%447.90M127.10M
FY201331 Dec 20131.37B+8.04%429.50M112.30M
FY201231 Dec 20121.27B+6.19%387.80M80.70M
FY201131 Dec 20111.19B+7.96%339.00M75.50M
FY201031 Dec 20101.10B+4.64%317.60M65.30M
FY200931 Dec 20091.06B+0.44%303.60M72.60M
FY200831 Dec 20081.05B+3.04%302.60M86.00M
FY200731 Dec 20071.02B+11.69%291.80M70.70M
FY200631 Dec 2006913.30M+30.53%261.80M67.10M
FY200531 Dec 2005699.70M+29.19%193.80M45.60M
FY200431 Dec 2004541.60M+10.37%167.50M19.40M
FY200331 Dec 2003490.70M+16.92%155.80M31.90M
FY200231 Dec 2002419.70M+5.74%117.60M18.40M
FY200131 Dec 2001396.90M-7.72%116.10M-5.20M
FY200031 Dec 2000430.10M-8.31%140.40M1.60M
FY199931 Dec 1999469.10M+4.31%180.00M38.70M
FY199831 Dec 1998449.70M-0.62%167.50M6.70M
FY199731 Dec 1997452.50M-1.37%164.00M44.40M
FY199631 Dec 1996458.80M+11.12%156.80M16.40M
FY199531 Dec 1995412.90M+13.09%147.80M28.70M
FY199431 Dec 1994365.10M+4.70%139.20M27.30M
FY199331 Dec 1993348.70M+3.10%126.60M23.50M
FY199231 Dec 1992338.20M+2.61%120.40M19.70M
FY199131 Dec 1991329.60M+1.98%108.20M-8.50M
FY199031 Dec 1990323.20M+4.70%101.70M4.30M
FY198931 Dec 1989308.70M+7.11%102.00M20.70M
FY198831 Dec 1988288.20M+13.78%90.80M17.40M
FY198731 Dec 1987253.30M+7.51%78.90M13.70M
FY198631 Dec 1986235.60M+23.93%75.40M17.00M
FY198531 Dec 1985190.10M—62.10M15.00M

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

West Pharmaceutical Services revenue growth by segment

Q3 FY2026 against Q3 FY2025

Proprietary Products728.80M
+12.6%

West Pharmaceutical Services revenue by segment over time

Proprietary Products Contract Manufactured Products
Fiscal yearProprietary ProductsContract Manufactured Products
FY20252.49B +6.8%582.00M +4.2%
FY20242.33B -2.6%558.70M +1.1%
FY20232.40B -0.4%552.50M +15.0%
FY20222.41B +3.9%480.40M -6.7%
FY20212.32B 514.70M +3.2%
FY2020— 498.60M +12.9%
FY2019— 441.50M +7.9%
FY2018— 409.10M +12.9%
FY2017— 362.50M +13.2%
FY2016— 320.20M

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Stock buybacks,Income statement

Common questions about West Pharmaceutical Services's revenue

Source: Financial Modeling Prep